SIGLEC1 and neoplasm: We demonstrated that TAMs are the major source of CCL8, and CCL8 and SIGLEC1 engage in a tumor cell-TAM regulatory loop, involving TNF-α, which in turn enhances their expression and leads to increased tumor cell motility.